SCICLONE PHARMACEUTICALS INC's ticker is SCLN and the CUSIP is 80862K104. A total of 129 filers reported holding SCICLONE PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 0.34 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $506,000 | +655.2% | 45,148 | +637.6% | 0.05% | +666.7% |
| Q2 2017 | $67,000 | -72.3% | 6,121 | -75.2% | 0.01% | -73.9% |
| Q1 2017 | $242,000 | +214.3% | 24,672 | +245.3% | 0.02% | +155.6% |
| Q4 2016 | $77,000 | -62.3% | 7,145 | -64.1% | 0.01% | -57.1% |
| Q3 2016 | $204,000 | +179.5% | 19,900 | +255.4% | 0.02% | +110.0% |
| Q2 2016 | $73,000 | +10.6% | 5,600 | -6.7% | 0.01% | +11.1% |
| Q1 2016 | $66,000 | -64.1% | 6,000 | -70.0% | 0.01% | -69.0% |
| Q4 2015 | $184,000 | +206.7% | 20,000 | +129.9% | 0.03% | +222.2% |
| Q3 2015 | $60,000 | -3.2% | 8,700 | +38.1% | 0.01% | 0.0% |
| Q2 2015 | $62,000 | +416.7% | 6,300 | +384.6% | 0.01% | +350.0% |
| Q1 2015 | $12,000 | -80.3% | 1,300 | -85.3% | 0.00% | -77.8% |
| Q3 2014 | $61,000 | +96.8% | 8,816 | +49.4% | 0.01% | +125.0% |
| Q2 2014 | $31,000 | – | 5,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sensato Investors LLC | 1,564,682 | $10,859,000 | 2.03% |
| Matarin Capital Management, LLC | 274,291 | $1,903,580,000 | 0.39% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 87,524 | $607,417,000 | 0.36% |
| TFS CAPITAL LLC | 323,415 | $2,245,000 | 0.22% |
| Nantahala Capital Management | 170,218 | $1,181,000 | 0.16% |
| Ativo Capital Management LLC | 74,338 | $592,000 | 0.16% |
| MENTA CAPITAL LLC | 111,985 | $777,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 229,891 | $1,595,000 | 0.11% |
| GSA CAPITAL PARTNERS LLP | 270,888 | $1,880,000 | 0.09% |
| BOOTHBAY FUND MANAGEMENT, LLC | 25,644 | $178,000 | 0.08% |